Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Tasmar Generic Name & Formulations
Legal Class
Rx
General Description
Tolcapone 100mg; tabs.
Pharmacological Class
COMT inhibitor.
How Supplied
Tabs—90
Manufacturer
Tasmar Indications
Indications
Adjunct to carbidopa/levodopa in idiopathic Parkinson's disease patients who have symptom fluctuations and for whom other adjunctive therapies are inappropriate or inadequate.
Tasmar Dosage and Administration
Adult
100mg three times daily; may cautiously increase to 200mg three times daily. Discontinue if no substantial benefit after 3 weeks.
Children
Not applicable.
Tasmar Contraindications
Contraindications
Liver disease (clinical evidence or serum transaminases 2xULN). Previous tolcapone-associated hepatocellular injury. History of non-traumatic rhabdomyolysis or fever and confusion possibly related to medication.
Tasmar Boxed Warnings
Boxed Warning
Risk of potentially fatal, acute fulminant liver failure.
Tasmar Warnings/Precautions
Warnings/Precautions
Obtain informed written consent. Risk of liver injury. Before starting and when increasing dose: do transaminases at baseline, then every 2–4 weeks for 6 months, then periodically if clinically relevant. Discontinue if signs/symptoms of liver disease (eg, jaundice, fatigue, anorexia) develop or if serum transaminases >2xULN. Reduce levodopa dose if dyskinesias appear or worsen. Orthostatic hypotension/syncope. Diarrhea (follow-up if persistent). Severe renal impairment (CrCl <25mL/min). Monitor for compulsive behaviors; consider reduce dose or discontinuation. Do periodic skin exam. Monitor patient closely when withdrawing therapy. Pregnancy (Cat.C). Nursing mothers.
Tasmar Pharmacokinetics
See Literature
Tasmar Interactions
Interactions
Concomitant non-selective MAOIs (eg, phenelzine, isocarboxazid, tranylcypromine): not recommended. Reduce concomitant levodopa dose. CNS depression potentiated with alcohol, other CNS depressants. May potentiate other drugs metabolized by COMT (eg, methyldopa, dobutamine, isoproterenol); monitor and reduce dose as needed. Monitor warfarin.
Tasmar Adverse Reactions
Adverse Reactions
Dyskinesias, nausea, sleep disorders, dystonia, excessive dreaming, anorexia, muscle cramps, orthostatic complaints, somnolence, diarrhea, confusion, dizziness, headache, hallucinations, vomiting, constipation, fatigue, upper respiratory or urinary tract infection, falling, increased sweating, syncope, xerostomia, urine discoloration (yellow); liver injury (may be fatal), rhabdomyolysis, hematuria, compulsive behavior, others.
Tasmar Clinical Trials
See Literature
Tasmar Note
Not Applicable
Tasmar Patient Counseling
See Literature
